RHHBY

ROCHE HLDGS AG BASEL

RHHBY·771195104·US·ADR·Healthcare - Drug Manufacturers - General

RHHBY (ROCHE HLDGS AG BASEL) is held by 6 institutional investors as of Q1 2026. Largest holders: Aristotle Capital Management, LLC ($102.1M), HUNTINGTON NATIONAL BANK ($6M), RHUMBLINE ADVISERS ($4.9M). Net institutional sentiment: Mixed. In Q1 2026, 2 members of Congress and 3 funds bought RHHBY.

6
Holders
(1 Elite)
$117M
Total Value
50% (6)
Consensus
3 buying - 3 selling
13F: Insider & Congress:
RHHBY

Smart Money Verdict

View all
Held by 6 funds
1 elite

Who's Trading

CongressAAAlan ArmstrongBuy $15,001 - $50,000Mar 30, 2026
CongressRitchie John TorresRitchie John TorresSale $1,001 - $15,000Jul 11, 2025
CongressBruce WestermanBruce WestermanSale $1,001 - $15,000Apr 21, 2025
CongressJosh GottheimerJosh GottheimerSale $1,001 - $15,000Apr 9, 2025
CongressBruce WestermanBruce WestermanSale $1,001 - $15,000Mar 3, 2025
CongressJosh GottheimerJosh GottheimerBuy $1,001 - $15,000Jul 23, 2024
CongressJosh GottheimerJosh GottheimerSale $1,001 - $15,000Jun 21, 2024

Top Holders

Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
2.1M(-2.1%)$102.1M0.2%+70.30%
0
New
122,990$6M0.0%-2.74%
38
Decreased
98,944(-0.3%)$4.9M0.0%+58.39%
0
Decreased
52,832(-30.5%)$2.6M0.0%+28.34%
0
Increased
23,456(+5.4%)$1.2M0.0%+39.10%
27
New
3,176$160,8270.0%-2.74%
31
RHHBYRHHBYROCHE HLDGS AG BASEL

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used